Karyopharm Therapeutics Inc.
US ˙ NasdaqGS ˙ US48576U1060

SecurityKPTI / Karyopharm Therapeutics Inc.
InsiderSohanya Roshan Cheng
This page shows the track record and history of Cheng Sohanya Roshan insider trades in Karyopharm Therapeutics Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Sohanya Roshan Cheng in KPTI / Karyopharm Therapeutics Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

KPTI / Karyopharm Therapeutics Inc. Insider Trades
Insider Sales - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Sohanya Roshan Cheng in KPTI / Karyopharm Therapeutics Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2025-09-15 325 6.4300 325 6.4300 2,090 4 5.4100 -331 -15.83
2025-03-04 3,445 6.2900 3,445 6.2900 21,669
2024-09-04 5,356 0.7218 357 10.8270 3,866
2024-03-01 5,109 1.2000 341 18.0000 6,131
2024-02-29 21,840 1.1700 1,456 17.5500 25,553
2023-09-01 7,415 1.3313 494 19.9695 9,872
2023-06-08 1,839 2.3500 123 35.2500 4,322
2023-03-01 11,239 3.0292 749 45.4380 34,045
2022-06-13 66 5.3450 4 80.1750 353
2022-06-13 1,485 5.2000 99 78.0000 7,722

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

KPTI / Karyopharm Therapeutics Inc. Insider Trades
Insider Transaction History
File
Date
Trade
Date
Form Insider Ticker Security Title Code 10b5-1 Direct Exercise
Price
Unit
Price
Units
Changed
Value
Changed (1K)
Remaining
Options
Remaining
Shares
2025-09-16 2025-09-15 4 Cheng Sohanya Roshan KPTI Common Stock S - Sale D 6.4300 -325 -2 35,856
2025-09-16 2025-09-12 4 Cheng Sohanya Roshan KPTI Common Stock A - Award D 945 36,181
2025-03-06 2025-03-04 4 Cheng Sohanya Roshan KPTI Common Stock S - Sale D 6.2900 -3,445 -22 34,314
2025-03-04 2025-02-28 4 Cheng Sohanya Roshan KPTI Common Stock A - Award D 4,583 37,759
2025-03-04 2025-02-28 4 Cheng Sohanya Roshan KPTI Common Stock A - Award D 5,416 33,176
2024-09-05 2024-09-04 4 Cheng Sohanya Roshan KPTI Common Stock S - Sale D 0.7218 -5,356 -4 404,051
2024-03-04 2024-03-01 4 Cheng Sohanya Roshan KPTI Common S - Sale D 1.2000 -5,109 -6 393,509
2024-03-04 2024-02-29 4 Cheng Sohanya Roshan KPTI Common S - Sale D 1.1700 -21,840 -26 398,618
2024-02-29 2024-02-28 4 Cheng Sohanya Roshan KPTI Common Stock A - Award D 198,959 420,458
2024-01-25 2024-01-24 4 Cheng Sohanya Roshan KPTI Common Stock A - Award D 14,167 221,499
2023-09-05 2023-09-01 4 Cheng Sohanya Roshan KPTI Common Stock S - Sale D 1.3313 -7,415 -10 204,086
2023-06-12 2023-06-08 4 Cheng Sohanya Roshan KPTI Common Stock S - Sale D 2.3500 -1,839 -4 211,501
2023-03-02 2023-03-01 4 Cheng Sohanya Roshan KPTI Common Stock S - Sale D 3.0292 -11,239 -34 210,687
2023-03-02 2023-02-28 4 Cheng Sohanya Roshan KPTI Common Stock A - Award D 100,000 221,926
2022-09-01 2022-08-31 4 Cheng Sohanya Roshan KPTI Common Stock A - Award D 30,000 119,949
2022-06-14 2022-06-13 4 Cheng Sohanya Roshan KPTI Common Stock S - Sale D 5.2000 -1,485 -8 89,949
2022-06-14 2022-06-13 4 Cheng Sohanya Roshan KPTI Common Stock S - Sale D 5.3450 -66 -0 91,434
2022-03-02 2022-02-28 4 Cheng Sohanya Roshan KPTI Stock Option (right to buy) A - Award D 10.33 108,000 108,000
2022-03-02 2022-02-28 4 Cheng Sohanya Roshan KPTI Common Stock A - Award D 84,000 91,500
2021-07-01 2021-06-30 4 Cheng Sohanya Roshan KPTI Nonstatutory Stock Option (right to buy) A - Award D 10.32 125,000 125,000
2021-07-01 2021-06-30 4 Cheng Sohanya Roshan KPTI Common Stock A - Award D 7,500 7,500
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)